Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 1 | Jenkins William D JrPresident |  PANWPalo Alto Networks IncOpen-market sale · 10b5-1 plan | SELL | $97K 280 sh | Nov 5, 2026 |
| 0 | Chang Fred FachingDirector, 10% Owner |  NEGGNewegg Commerce, Inc.Open-market sale · 10b5-1 plan | SELL | $33K 3,582 sh | Nov 5, 2026 traded Nov 3, 2026 |
| 0 | Jenkins William D JrPresident | PANWPalo Alto Networks Inc Open-market sale · 10b5-1 plan | SELL | $29K 80 sh | Nov 5, 2026 traded Nov 4, 2026 |
| 0 | Chang Fred FachingDirector, 10% Owner | NEGGNewegg Commerce, Inc. Open-market sale · 10b5-1 plan | SELL | $35K 3,582 sh | Nov 5, 2026 traded Nov 4, 2026 |
| 0 | Gallup PatriciaDirector, Chairman & Chief Admin Officer, 10% Owner |  CNXNPC CONNECTION INCOpen-market sale · 10b5-1 plan | SELL | $14K 154 sh | Nov 5, 2026 traded Nov 3, 2026 |
| 0 | Jenkins William D JrPresident | PANWPalo Alto Networks Inc Open-market sale · 10b5-1 plan | SELL | $27K 80 sh | Nov 5, 2026 traded Nov 4, 2026 |
| 0 | Gallup PatriciaDirector, Chairman & Chief Admin Officer, 10% Owner | CNXNPC CONNECTION INC Open-market sale · 10b5-1 plan | SELL | $9,074 102 sh | Nov 5, 2026 traded Nov 4, 2026 |
| 53 | Sing George LDirector |  REGNREGENERON PHARMACEUTICALS, INC.Open-market sale | SELL | $6.83M 7,073 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 49 | Larosa Joseph JEVP General Counsel and Secret | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $3.80M 3,939 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 49 | Garceau Mary LSVP - CLO and Secretary |  SHWSHERWIN WILLIAMS COOpen-market sale | SELL | $1.36M 3,891 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 49 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $1.47M 1,522 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 49 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $4.18M 4,338 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 49 | Way T LawrenceDirector |  CUBICustomers Bancorp, Inc.Open-market sale | SELL | $4.09M 48.8K sh | Nov 4, 2026 traded Oct 30, 2026 |
| 49 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $2.58M 2,670 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 49 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $2.43M 2,522 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 47 | Skeete Bernard MChief Accounting Officer |  VLTOVeralto CorpOpen-market sale | SELL | $170K 1,514 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 45 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $1.18M 1,224 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 45 | Pope Daniel MDirector |  TYLTYLER TECHNOLOGIES INCOpen-market sale | SELL | $277K 680 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 45 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $1.01M 1,040 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 44 | Treff Douglas JDirector |  CROXCrocs, Inc.Open-market sale | SELL | $1.10M 7,185 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 44 | Clay CraigSenior Advisor |  DFINDonnelley Financial Solutions, Inc.Open-market sale | SELL | $1.45M 21.5K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 44 | Clay CraigSenior Advisor | DFINDonnelley Financial Solutions, Inc. Open-market sale | SELL | $1.89M 28.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 44 | Clay CraigSenior Advisor | DFINDonnelley Financial Solutions, Inc. Open-market sale | SELL | $1.45M 21.4K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 43 | Bichara GuillermoExec VP & Chief Legal Officer |  LINLINDE PLCOpen-market sale | SELL | $4.85M 9,350 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 42 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $519K 540 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 42 | Murphy Robert MadisonDirector |  MUSAMurphy USA Inc.Open-market sale | SELL | $589K 1,000 sh | Nov 4, 2026 traded May 4, 2026 |
| 42 | Larosa Joseph JEVP General Counsel and Secret | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $509K 527 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 41 | Turner KamiChief Accounting Officer | DFINDonnelley Financial Solutions, Inc. Open-market sale | SELL | $406K 6,100 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 41 | Turner KamiChief Accounting Officer | DFINDonnelley Financial Solutions, Inc. Open-market sale | SELL | $406K 6,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 40 | Olschan Brian SDirector, President and COO |  ACUACME UNITED CORPOpen-market sale | SELL | $982K 14.2K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 39 | Heyer Andrew RDirector |  OSWONESPAWORLD HOLDINGS LtdOpen-market sale | SELL | $183K 7,000 sh | Nov 4, 2026 traded Aug 20, 2026 |
| 39 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $194K 200 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 38 | Murphy Robert MadisonDirector | MUSAMurphy USA Inc. Open-market sale | SELL | $624K 1,000 sh | Nov 4, 2026 traded Jul 29, 2026 |
| 38 | Lindquist Scott REVP & CFO |  CNACNA FINANCIAL CORPOpen-market sale | SELL | $1.12M 23.6K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 38 | Chybowski Joseph M.PRESIDENT & CFO |  BWBBridgewater Bancshares IncOpen-market sale | SELL | $197K 9,651 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 37 | Treff Douglas JDirector | CROXCrocs, Inc. Open-market sale | SELL | $515K 3,416 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 37 | Murphy Susan HDirector | ACUACME UNITED CORP Open-market sale | SELL | $194K 2,890 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 37 | Clay CraigSenior Advisor | DFINDonnelley Financial Solutions, Inc. Open-market sale | SELL | $986K 14.5K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 37 | Clay CraigSenior Advisor | DFINDonnelley Financial Solutions, Inc. Open-market sale | SELL | $309K 4,500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 37 | Treff Douglas JDirector | CROXCrocs, Inc. Open-market sale | SELL | $471K 3,101 sh | Nov 4, 2026 traded Nov 2, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K